2026-08-26

A hospital procurement manager shares six practical checks before signing a medical device PO — covering cardiac defibrillators, mass spectrometers, Boston Scientific core values, the Nalu Medical acquisition, and total cost of ownership.

If You Sign Medical Device POs, This Checklist Is for You

I'm a procurement manager at a 500-bed health system. I've managed our capital equipment budget for six years, negotiated with 40+ vendors, and built a cost-tracking system that catches what most purchase orders ignore. This is the checklist I run before I sign any major device contract.

Use it when you're evaluating a cardiac defibrillator line, a mass spectrometer for the lab, or any other capital purchase that will live in your hospital for five to seven years. It's six checks, not sixty. And it takes less time than a back-and-forth email chain about a pricing spread.

Check 1: Answer the 'What Is Clinical Chemistry?' Question Before You Look at Any Device

Here's what you need to know: most procurement pain starts because the clinical request has a device name but no clinical problem. 'We need a mass spectrometer' isn't enough. Neither is 'we need a cardiac defibrillator.'

Let's get one common one out of the way. What is clinical chemistry? In simple terms, it's the lab discipline that measures glucose, electrolytes, creatinine, liver enzymes, and similar molecules in blood or other body fluids. A clinical chemistry analyzer handles those routine, high-volume tests. A mass spectrometer, on the other hand, identifies molecules by mass-to-charge ratio and is usually used for specialized assays like therapeutic drug monitoring or newborn screening. If you buy one when you actually needed the other, you'll own an expensive instrument that doesn't fit the billing pathway.

So before the vendor demo, write one sentence on the capital request: the clinical problem, the patient population, the monthly volume, and the systems it has to integrate with. If you can't write that sentence, the rest of the checklist isn't safe to run.

Check 2: Calculate Total Cost of Ownership, Not the Sticker Price

From the outside, it looks like a capital purchase is about the sticker price. The reality is it's about a seven-year stream of service contracts, consumables, software updates, training, replacement parts, and downtime.

People assume the lowest quote means the vendor is more efficient. What they don't see is which costs are hidden or deferred. When I compared two cardiac defibrillator vendors last year, the lower quote had a separate charge for every remote follow-up session after the first one. The 'more expensive' vendor included remote checks in its service plan. Over five years, the cheap quote was actually 23% more expensive in total cost.

I didn't see that until I built a simple TCO spreadsheet. Trust me on this one: if a vendor is not willing to give you all the following in writing, it's a red flag:

  • Installation and site preparation
  • Service contract and response-time guarantee
  • Software updates and cybersecurity patches
  • Consumables per test or procedure
  • Training and go-live support
  • Data migration and exit fees

For a mass spectrometer, consumables can dwarf the sticker price. For an implantable cardiac defibrillator system, the service and patient follow-up workflow can make or break the clinical team's adoption. Same logic, different numbers.

Check 3: Use Boston Scientific Core Values as a Contract Test

If you hear a rep say 'we're a partner' and there's no contractual behavior behind it, you're not in a partnership. You're in a sales conversation.

That's why I use published core values as a checklist. Boston Scientific core values, as listed on its corporate site as of February 2025, are Caring, Collaboration, Diversity, Innovation, Integrity, Quality, and Sustainability. I don't ask the rep to recite them. I ask them to show me where the contract supports them.

Here's what that looks like:

  • If Integrity is a value, the quote should list setup fees, not hide them until after PO.
  • If Quality is a value, there should be a written process for field action notification and recall alerts.
  • If Caring is a value, the training plan should include clinical specialist hours at go-live, not just a video library login.

You can apply the same test to any manufacturer. The words are only useful when they create a standard you can hold the vendor to.

Check 4: Follow the Roadmap: Boston Scientific to Acquire Nalu Medical 2025

M&A headlines are procurement clues. When the phrase 'Boston Scientific to acquire Nalu Medical 2025' started appearing in January, I didn't just send it to my board chair. I asked what it meant for our capital plan.

Nalu Medical makes minimally invasive peripheral nerve stimulation systems. An acquisition like that tells you a vendor is investing in pain management rather than sunsetting it. But a press release is not a guarantee. If you're evaluating a device that is being acquired or migrated, ask the vendor:

  • Will this current model continue to be supported?
  • What happens to the service contract if the portfolio is consolidated?
  • Who provides training and clinical support during the transition?

If the vendor says, 'nothing changes,' ask them to put that in a lifecycle letter. The acquisition news is useful context, not a promise.

Check 5: Run a Site Readiness Review Before You Sign (Not After)

I know I should have done this on one project. I skipped it because I thought 'the new mass spectrometer is basically the same as the old one. What are the odds?' The odds caught up with me. The installation required a dedicated power feed and a vibration-damped bench that nobody had budgeted for. That became a $17,000 change order.

Different equipment has different physical and IT requirements. A cardiac defibrillator system with a networked programmer needs a reliable network, backup power for the programmer cart, and a quiet space for interrogation. A mass spectrometer needs clearance for gas cylinders, ventilation, exhaust, and possibly a specific water supply. The quote usually doesn't include those site costs.

Make a site readiness review a condition of the PO. If the vendor won't do one, hire an independent biomedical engineer. $2,000 now beats $17,000 later (ugh).

Check 6: Negotiate the Exit, Not Just the Entry

Every contract eventually ends. The question is whether your data comes with you.

When I negotiated a new lab instrument contract, I asked for a data export guarantee. The vendor hesitated. That hesitation told me more than any marketing slide.

Ask these questions before you sign:

  • What data can you export if we terminate?
  • What format is the export in?
  • How long does the transition take?
  • Is there an onboarding fee for the replacement vendor?

If the answers are vague, that's a future cost. It's like checking the brakes on a car before you buy it, not after you're driving downhill.

Final Thought: Prevention Beats Correction, Every Time

I've built this checklist from my own mistakes, not from a textbook. The 5-minute verification I skipped cost $17,000. The 30-minute TCO spreadsheet I ran saved $40,000.

That's the whole argument for a checklist: it's the cheapest insurance you'll ever buy. It doesn't make the decision exciting. It makes it survivable.

So, next time your clinical team hands you a request for a mass spectrometer, a cardiac defibrillator, or the latest device from a company going through an acquisition, run these six checks. The sticker price is only the beginning. The total cost is what happens after you sign.

Jane Smith

I’m Jane Smith, a senior content writer with over 15 years of experience in the packaging and printing industry. I specialize in writing about the latest trends, technologies, and best practices in packaging design, sustainability, and printing techniques. My goal is to help businesses understand complex printing processes and design solutions that enhance both product packaging and brand visibility.